TLR4 and amyotrophic lateral sclerosis: Multiple studies have demonstrated that inhibition and/or genetic deletion of RAGE, TLR4, or C5aR1 has beneficial effects on survival and disease progression in animal models of ALS [6–11], suggesting that these immune receptors play a pathogenic role in the disease.